Spinal Cord Injury Pain

• FDA approval · 2024-01-24
  FDA Approved: PREGABALIN — Supplemental Application (MARKSANS PHARMA LIMITED)

  FDA approved a supplemental application for pregabalin submitted by Marksans Pharma Limited (ANDA 216197).

• FDA approval · 2022-07-18
  FDA Approved: PREGABALIN — Original Application (MARKSANS PHARMA LIMITED)

  FDA approved the original ANDA for pregabalin from Marksans Pharma Limited (ANDA216197).

• FDA approval · 2019-07-19
  FDA Approved: PREGABALIN — Original Application (Rising Pharma Holdings, Inc.)

  FDA approved the original application for pregabalin (generic) submitted by Rising Pharma Holdings, Inc., authorizing its market authorizati…

• FDA approval · 2019-07-19
  FDA Approved: PREGABALIN — Original Application (Alembic Pharmaceuticals Inc.)

  The FDA approved Alembic Pharmaceuticals' original ANDA for pregabalin, enabling a generic version of pregabalin to be marketed. The approva…

• FDA approval · 2007-06-21
  FDA Approved: LYRICA — Supplemental Application (Parke-Davis Div of Pfizer Inc)

  The FDA approved a supplemental application for LYRICA (pregabalin) submitted by Parke-Davis (Pfizer) to update the labeling with expanded o…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.